860637P
Avanti
Galactosyl(β) Sphingosine-d5
Avanti Research™ - A Croda Brand
동의어(들):
D-galactosyl-β1-1′-D-erythro-sphingosine-d5
제품 이름
Galactosyl(β) Sphingosine-d5, Avanti Research™ - A Croda Brand 860637P, powder
분석
>99% (TLC)
양식
powder
포장
pkg of 1 × 1 mg (860637P-1mg)
제조업체/상표
Avanti Research™ - A Croda Brand 860637P
배송 상태
dry ice
저장 온도
−20°C
SMILES string
[H][C@](/C=C/CCCCCCCCCCCC([2H])(C([2H])([2H])[2H])[2H])(O)[C@](N)([H])CO[C@H](O1)[C@H](O)[C@@H](O)[C@H]([C@H]1CO)O
InChI key
HHJTWTPUPVQKNA-LTNFHSIGSA-N
애플리케이션
Galactosyl(β) Sphingosine-d5 has been used as an internal standard for the quantification of galactosylsphingosine, in the extracts from the mouse cerebellum by liquid chromatography-tandem mass spectrometry.
생화학적/생리학적 작용
Galactosylsphingosine, also known as psychosine, has an ability to induce apoptosis in various types of cells including oligodendrocytes. It is a toxic metabolite. Accumulation of this cytotoxic sphingolipid in the brain due to the deficiency of galactocerebrosidase (GALC) leads to the development of Krabbe disease.
포장
5 mL Amber Glass Screw Cap Vial (860637P-1mg)
법적 정보
Avanti Research is a trademark of Avanti Polar Lipids, LLC
Storage Class Code
11 - Combustible Solids
Flash Point (°F)
No data available
Flash Point (°C)
No data available
Victoria Schiffer et al.
PloS one, 15(1), e0227077-e0227077 (2020-01-14)
Gaucher disease is caused by a deficiency in glucocerebrosidase that can result in non-neuronal as well as neuronal symptoms. Common visceral symptoms are an increased organ size, specifically of the spleen, and glucosylceramide as well as glucosylsphingosine substrate accumulations as
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.